Cargando…
A multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA)
BACKGROUNDS: To determine the true incidence of hGISA/GISA and its consequent clinical impact, methods must be defined that will reliably and reproducibly discriminate these resistant phenotypes from vancomycin susceptible S. aureus (VSSA). METHODS: This study assessed and compared the ability of ei...
Autores principales: | Voss, Andreas, Mouton, Johan W, van Elzakker, Erika P, Hendrix, Ron G, Goessens, Wil, Kluytmans, Jan A, Krabbe, Paul F, de Neeling, Han J, Sloos, Jacobus H, Oztoprak, Nefise, Howe, Robin A, Walsh, Timothy R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034580/ https://www.ncbi.nlm.nih.gov/pubmed/17892555 http://dx.doi.org/10.1186/1476-0711-6-9 |
Ejemplares similares
-
GISA: using Gauss Integrals to identify rare conformations in protein structures
por: Grønbæk, Christian, et al.
Publicado: (2020) -
Decrease in vancomycin MICs and prevalence of hGISA in MRSA and MSSA isolates from a German pediatric tertiary care center
por: Haas, Katharina, et al.
Publicado: (2023) -
Emergence of Methicillin-Resistant Staphylococcus aureus of Animal Origin in Humans
por: van Loo, Inge, et al.
Publicado: (2007) -
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus.
por: Tenover, F C, et al.
Publicado: (2001) -
The Efficacy and Safety of Linezolid and Glycopeptides in the Treatment of Staphylococcus aureus Infections
por: Fu, Jinjian, et al.
Publicado: (2013)